US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.580
  • +0.230+6.87%
Close Nov 1 16:00 ET
  • 3.450
  • -0.130-3.63%
Post 20:02 ET
151.96MMarket Cap-2196P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Repare Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.733M--
--2024/Q3-- / 2.733M--
--2024/Q21.073M / 2.929M--
--2024/Q152.404M / 38.400M--
--2023/Q413.047M / 18.931M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.733M--
--2024/Q3-- / 2.733M--
--2024/Q21.073M / 2.929M--
--2024/Q152.404M / 38.400M--
--2023/Q413.047M / 18.931M--

Unlock Free Earnings Estimates

Repare Therapeutics Earnings Reports

  • Repare Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:24 ET

  • Repare Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 16:22 ET

  • Repare Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 07:17 ET

  • Repare Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 07:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data